Please Read Our Disclaimer

An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Vaccine (Video)

An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Vaccine (Video)

In an online presentation, Dr. Maria Gutschi provides an overview of her independent investigation into the quality issues with the BNT162B2 BioNTech/Pfizer vaccine that were identified by the European Medicines Agency.

Tags: amino acids, autoimmunity, batches, biodistribution, cationic lipids, clinical trials, codons, COVID-19, efficacy, European Medicines Agency (EMA), gene therapy, impurities, lipid nanoparticles, mRNA, PEGlayted lipid, regulatory agencies, safety, syncytin-1, synthetic, translation, vaccines

Share:

Related Posts

Florida’s Surgeon General challenges the FDA and CDC.

The balance of risks and benefits in the COVID-19 “vaccine hesitancy” literature: An umbrella review

Left unchecked, the arbitrary power of the College of Physicians and Surgeons of BC threatens the health and well-being of all British Columbians as well as the core values of Canadian democracy

Search

Top Categories

WANT TO BECOME A MEMBER?

To learn more about how you can join the Canadian Covid Care Alliance click the link below.

Popular Posts

Real Time Ethics – About Misinformation, Disinformation, and Scientific Discourse

The Endemic Hypothesis: Infectious Clones and Virus Isolation

You’ve been “Nudged”!

The Building Case Against COVID-19 Vaccination of Students in Canada

Letter to Members of the BC Legislative Assembly Requesting the Repeal of the Health Professions and Occupations Act

Stay Connected

Canadian Covid Care Alliance